Low Iron in Melanoma: What It Means and What To Do

Low iron (often reflected by low ferritin and/or low transferrin saturation) usually indicates iron deficiency and can lead to anemia, which is common in people with cancer for several reasons. In many cases, low iron is manageable and does not directly worsen melanoma treatment outcomes, but it deserves a proper work‑up to find the cause and correct it.

---

Why Iron Can Be Low

• Blood loss: Occult bleeding from the gastrointestinal (GI) tract is a frequent cause of iron deficiency. In people with a history of melanoma, rare GI metastases can present with iron‑deficiency anemia and symptoms like fatigue or chest discomfort. Detecting and treating the underlying cause can lead to good outcomes. [PM7] [PM9]
• Inflammation and treatment effects: Cancer‑related inflammation increases hepcidin (a hormone that traps iron in storage), causing “functional iron deficiency” where ferritin may be normal or high but transferrin saturation is low, limiting iron available for red blood cell production. This pattern is common in cancer and can be treated. [PM18]
• Nutrition and absorption issues: Reduced intake, malabsorption (e.g., celiac disease, gastritis), or postoperative changes can limit iron uptake. A structured diagnostic approach helps identify these. [PM22]

---

Does Low Iron Affect Melanoma Outcomes?

• Anemia is linked to worse tolerance of therapy across several cancers, and correcting iron deficiency can improve hemoglobin and reduce transfusion needs. However, simply normalizing hemoglobin has not consistently shown a survival benefit on its own, suggesting other factors contribute to outcomes. ^{[1] [2] [3]}
• In melanoma specifically, low iron is more a red flag to investigate causes (especially GI bleeding) than a direct driver of melanoma progression. Case reports highlight that iron‑deficiency anemia can occasionally unmask GI metastases; timely endoscopic evaluation leads to appropriate melanoma therapy and can result in durable remission. [PM7] [PM9]

---

Symptoms to Watch

• Fatigue, shortness of breath, dizziness
• Pale skin, fast heartbeat
• Black or tarry stools, visible blood in stool, unexplained weight loss, persistent abdominal pain

If any GI bleeding symptoms are present with low iron, a bidirectional endoscopy (upper endoscopy and colonoscopy) is generally recommended to look for a source. [PM22]

---

How Low Iron Is Diagnosed

• Key labs: Hemoglobin, ferritin, transferrin saturation (TSAT), serum iron, total iron‑binding capacity.

  • Absolute iron deficiency often shows ferritin <100 ng/mL with TSAT <20%. [PM18]
  • Functional iron deficiency may show TSAT <20% with normal or elevated ferritin due to inflammation. This still limits red blood cell production and is treatable. [PM18]

• Evaluate causes:

  • GI work‑up (upper and lower endoscopy) when iron deficiency is unexplained, especially in adults and those with alarm features. [PM22]
  • Screen for celiac disease (IgA tissue transglutaminase and total IgA), assess medications (e.g., NSAIDs), and consider malabsorption or chronic inflammation. [PM22]

---

Treatment Options

• Oral iron: Often first‑line for absolute iron deficiency (typical elemental iron 100–200 mg daily), but it can take 3–6 months to replenish stores and may cause side effects or be less effective in inflammation. [PM22]
• Intravenous (IV) iron: Preferred when rapid correction is needed, oral iron isn’t tolerated or effective, or functional iron deficiency is present. IV iron can improve hemoglobin, augment response to erythropoiesis‑stimulating agents (ESAs), and reduce transfusion needs in cancer‑related anemia. [PM18] [PM19] [PM20]
• ESAs: Considered in chemotherapy‑associated anemia when benefits outweigh risks; they are used at the lowest effective dose to avoid transfusions and carry cautions about tumor progression risk in certain cancers. ^[4]
• Transfusion: Used for significant symptomatic anemia; clinicians aim to minimize transfusions due to risks and resource limitations, favoring iron therapy when appropriate. [PM18]
• Perioperative setting: In planned cancer surgeries, IV iron is increasingly used preoperatively to reduce transfusion requirements and optimize recovery. [PM21]

---

Practical Next Steps

• Ask for a complete anemia panel: Hemoglobin, ferritin, TSAT, serum iron, and inflammatory markers.
• Discuss GI evaluation: If iron deficiency is new or unexplained, especially with GI symptoms, consider upper and lower endoscopy. This approach is widely recommended to rule out bleeding or rare metastases. [PM22] [PM7] [PM9]
• Choose iron therapy based on type of deficiency:
  • Absolute deficiency: oral iron may be reasonable if tolerated and effective. [PM22]
  • Functional deficiency or rapid needs: IV iron is often more effective. This can reduce transfusions and improve energy levels. [PM18] [PM19]
• Coordinate with your oncology team: Managing anemia alongside melanoma care ensures treatments (e.g., immunotherapy, targeted therapy) proceed safely.

---

When to Be Concerned

• Persistent or severe anemia symptoms (e.g., chest pain, fainting) warrant urgent attention and possible transfusion. Even then, the long‑term plan should focus on finding and treating the cause. [PM18]
• Signs of GI bleeding or unexplained iron deficiency should prompt timely evaluation; in those with a past melanoma, endoscopy can detect rare but important GI involvement, enabling appropriate oncologic treatment and good outcomes. [PM7] [PM9]

---

Key Takeaways

• Low iron in melanoma is common and usually treatable. It often reflects iron‑deficiency anemia from bleeding, inflammation, or malabsorption. [PM18] [PM22]
• Correcting iron especially with IV iron in the right scenarios can improve hemoglobin and reduce transfusions, supporting overall care. [PM18] [PM19] [PM20]
• A structured evaluation for causes (including GI work‑up when appropriate) is important, particularly if iron deficiency is new or unexplained. [PM22] [PM7] [PM9]
• While anemia can correlate with worse tolerance in various cancers, simply fixing hemoglobin hasn’t consistently improved survival, so comprehensive care remains key. ^{[2] [3] [1]}

If you’d like, I can help interpret your latest lab results and suggest tailored next steps.